Methotrexate vs Tofacitinib
Compare Methotrexate and Tofacitinib side by side: what they treat, drug class, cost and FDA label information.
| Methotrexate | Tofacitinib | |
|---|---|---|
| Drug class | Folate Analog Metabolic Inhibitor | Janus Kinase Inhibitor |
| Used to treat | Breast neoplasms, Choriocarcinoma, Crohn disease, Esophageal neoplasms, Hydatidiform mole, Juvenile arthritis, Leukemia, Lung neoplasms, Mycosis fungoides, Osteosarcoma, Psoriasis, Rheumatoid arthritis, Stomach neoplasms, Testicular neoplasms | Rheumatoid arthritis |
| Generic price | From $0.16 each, about $4.73 for 30 (2.5 mg tablet); other forms from $0.70 per mL (250 mg/10 mL vial) | From $0.57 each, about $17.18 for 30 (5 mg tablet) |
| Brand price | No brand price listed | Xeljanz: from $73.77 each, about $2,213 for 30 (5 mg tablet) |
| Generic savings | Not listed | Generic costs over 99% less than the brand |